Karyopharm Receives Conditional MA in the UK for NEXPOVIO® (selinexor) for the Treatment of Multiple Myeloma
UK's MHRA granted conditional marketing authorization for NEXPOVIO® (selinexor) of Karyopharm Therapeutics
Read more
Tag: Karyopharm
UK's MHRA granted conditional marketing authorization for NEXPOVIO® (selinexor) of Karyopharm Therapeutics
Read more